Federal contract award
75N91023C00059
DEVELOPMENT OF DIGITAL SATIORX, A VERY LOW COST REMOTELY CONTROLLABLE DISPOSABLE MICRONEEDLE TRANSDERMAL DRUG DELIVERY DEVICE ABLE TO DELIVER ANY LIQUID FDA APPROVED TRANSDERMAL DRUG
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H) |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | SMALL BUSINESS SET ASIDE - TOTAL |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $3.5M |
| Current contract value | $3.5M |
| Potential contract value / ceiling | $3.5M |
| Start date | Sep 30, 2023 |
| Current end date | Feb 3, 2026 |
| Potential end date | Feb 3, 2026 |
| Latest award activity | Feb 3, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Feb 3, 2026 | P00005 | $0 | DEVELOPMENT OF DIGITAL SATIORX, A VERY LOW COST REMOTELY CONTROLLABLE DISPOSABLE MICRONEEDLE TRANSDERMAL DRUG DELIVERY DEVICE ABLE TO DELIVER ANY LIQUID FDA APPROVED TRANSDERMAL DRUG |
| Apr 30, 2025 | P00004 | $0 | DEVELOPMENT OF DIGITAL SATIORX, A VERY LOW COST REMOTELY CONTROLLABLE DISPOSABLE MICRONEEDLE TRANSDERMAL DRUG DELIVERY DEVICE ABLE TO DELIVER ANY LIQUID FDA APPROVED TRANSDERMAL DRUG |
| Mar 12, 2025 | P00003 | $0 | DEVELOPMENT OF DIGITAL SATIORX, A VERY LOW COST REMOTELY CONTROLLABLE DISPOSABLE MICRONEEDLE TRANSDERMAL DRUG DELIVERY DEVICE ABLE TO DELIVER ANY LIQUID FDA APPROVED TRANSDERMAL DRUG |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Mary Muir | Contact | mary.muir@nih.gov 2402766533 | Source | Jun 27, 2023 |
| Mary Muir | Contact | mary.muir@nih.gov 2402766533 | Source | Jun 22, 2023 |
| Mary Muir | Contact | mary.muir@nih.gov 2402766533 | Source | Jun 16, 2023 |
| Mary Muir | Contact | mary.muir@nih.gov 2402766533 | Source | Jun 12, 2023 |
| Mary Muir | Contact | mary.muir@nih.gov 2402766533 | Source | Jun 12, 2023 |
| Mary Muir | Contact | mary.muir@nih.gov 2402766533 | Source | Jun 2, 2023 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.